Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

On Friday, DexCom Inc (DXCM) stock saw a decline, ending the day at $80.24 which represents a decrease of $-0.33 or -0.41% from the prior close of $80.57. The stock opened at $80.03 and touched a low ...

Morgan Stanley has recently reduced ING Groep NV (ING) stock rating, as announced on November 26, 2024, according to Finviz. Earlier, on October 22, 2024, Barclays had reduced the stock from a ...

In the words of MicroStrategy co-founder Michael Saylor, 2024 was “year zero of institutional adoption.” Speaking of Saylor, ...

The past two years have been absolutely incredible for investors in Nvidia (NASDAQ: NVDA) as shares of the semiconductor ...

Morgan Stanley analyst Stephen Byrd suggested buying power companies he thought could benefit from the AI boom.

Experts say the playing field has fundamentally changed as fractional ownership and other paths to access make alternative ...

Companies take advantage of huge investor demand to pull forward bond issuance originally planned for next year ...

The Morgan Stanley executive is retiring to run a foundation she started that aims to bring more young women into wealth ...

Another ASX share that could be a buy in 2025 is wine giant Treasury Wine Estates. With the China market reopening to ...